However, recent efforts have used the NADH-ubiquinone oxidoreductase chain 4 (ND4) and the RNA transport-derived stem-loop element (RP-loop) to improve the efficiency of mtDNA modification, demonstrating the potential use of this system to target mitochondrial diseases [116]. This evidence concerns the gene MT-ND4 and inborn mitochondrial metabolism disorder.